Biomet Retains Heidrick & Struggles and The McLoughlin Company to Assist in CEO Search

Biomet Inc. (NASDAQ:BMET) today announced that it has
retained the services of Heidrick & Struggles, one of the world's
premier executive search and leadership consulting firms, and The
McLoughlin Company, an advisor on institutional management, to conduct
a global search for candidates to serve as Biomet's President and
Chief Executive Officer. Dane A. Miller, PhD, resigned from the
position of President and CEO on March 27, 2006, at which time Daniel
P. Hann assumed the role of Interim President and CEO.
   The Board of Directors will carefully consider both internal and
external candidates in its search for a new President and CEO. It is
pleased to partner with respected, top-level firms like Heidrick &
Struggles and The McLoughlin Company. Their use of best management
practices, their global reach and depth of experience in the medical
devices industry will help ensure a smooth transition to the next era
of leadership.
   Leading the search team from Heidrick & Struggles are William A.
Matthews, Partner, Atlanta, and David L. Vied, Partner, Los Angeles.
Paul McLoughlin represents The McLoughlin Company.

   About Heidrick & Struggles International, Inc.

   Heidrick & Struggles International, Inc. (NASDAQ:HSII) is the
world's premier provider of senior-level executive search and
leadership consulting services, including talent management, board
building, executive on-boarding and M&A effectiveness. For more than
50 years, the company has focused on quality service and built strong
leadership teams through their relationships with clients and
individuals worldwide. Today, their leadership experts operate from
principal business centers in North America, Latin America, Europe and
Asia Pacific. For more information about Heidrick & Struggles, visit
www.heidrick.com.

   About The McLoughlin Company

   The McLoughlin Company is a sole proprietorship providing a broad
range of advisory services to boards, CEOs and senior executive teams
at corporations, not-for-profit institutions, and financial service
firms with focus on senior management, marketing, and technology. For
more information about The McLoughlin Company visit
www.themcloughlincompany.com.

   About Biomet, Inc.

   Biomet, Inc. and its subsidiaries design, manufacture and market
products used primarily by musculoskeletal medical specialists in both
surgical and non-surgical therapy. The Company's product portfolio
encompasses reconstructive products, including orthopedic joint
replacement devices, bone cements and accessories, and dental
reconstructive implants; fixation products, including electrical bone
growth stimulators, internal and external orthopedic fixation devices,
craniomaxillofacial implants and bone substitute materials; spinal
products, including spinal stimulation devices, spinal hardware and
orthobiologics; and other products, such as arthroscopy products and
softgoods and bracing products. Headquartered in Warsaw, Indiana,
Biomet and its subsidiaries currently distribute products in more than
100 countries.